{"doi":"10.1002/acr.25683","title":"Prevalence of Arthritis‐Attributable Work Limitations Among Adults Aged 18–64 Years With Arthritis: United States, 2023","abstract":"OBJECTIVE: This cross-sectional study estimates national prevalence of arthritis-attributable work limitations (AAWL), describes differences in prevalence of AAWL by selected demographic and health characteristics, and assesses progress toward the AAWL Healthy People 2030 objective from 2019 to 2023. METHODS: Using data from the 2023 National Health Interview Survey, unadjusted and age-standardized prevalence of AAWL were estimated overall and by selected demographic and health characteristics. Data were age-standardized using four age groups (18-34, 35-44, 45-54, 55-64 years). t tests assessed differences by population subgroup and by data year (2019 and 2023). Age-standardized prevalence was reported when making comparisons. RESULTS: In 2023, the age-standardized prevalence of AAWL among US adults with arthritis aged 18 to 64 years was 38.8% (95% confidence interval 35.6-42.2). AAWL was significantly higher among Hispanic (50.1%) and non-Hispanic American Indian and Alaska Native adults (55.9%) compared to non-Hispanic White adults (35.6%). AAWL was higher among those with a disability (62.1%) than without (33.5%), those unable to work or who were disabled (61.8%) than employed/self-employed (32.2%), and veterans (52.5%) than nonveterans (37.8%). Respondents rating their health status as poor/fair (61.1%) or good (33.0%) had higher prevalence of AAWL than those with excellent/very good health status (23.9%). Adults with difficulty walking or climbing stairs (68.5%) had higher prevalence of AAWL compared to adults without difficulty (35.1%). The prevalence of AAWL during 2019 (38.1%) and 2023 (38.8%) was not significantly different. CONCLUSION: More than one-third of US adults aged 18 to 64 years with arthritis report AAWL. Promoting arthritis-appropriate evidence-based interventions is important for achieving the Healthy People 2030 AAWL objective.","journal":"Arthritis Care & Research","year":2025,"id":578961,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":0.0,"corpus_rank":10477,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":true,"is_dataset_confidence":0.6132,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1489229,"name":"Fu Zhao","orcid":null,"position":1,"is_corresponding":false},{"id":434957,"name":"Michael A. Boring","orcid":null,"position":2,"is_corresponding":false},{"id":433983,"name":"Kamil E. Barbour","orcid":"0000-0003-0546-6742","position":3,"is_corresponding":false},{"id":1142989,"name":"Elizabeth A. Fallon","orcid":"0000-0002-9083-6682","position":4,"is_corresponding":false},{"id":404243,"name":"Daniel K. White","orcid":"0000-0003-3792-4621","position":0,"is_corresponding":true}],"reference_count":0,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T02:58:24.957414Z","pmid":"41132107","pmcid":"PMC13137577","fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}